Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Shanghai - Delayed Quote CNY

ChongQing Zhengchuan Pharmaceutical Packaging Co.,Ltd (603976.SS)

Compare
16.72
-0.04
(-0.24%)
At close: April 18 at 3:00:03 PM GMT+8
Loading Chart for 603976.SS
  • Previous Close 16.76
  • Open 16.76
  • Bid 16.72 x --
  • Ask 16.74 x --
  • Day's Range 16.46 - 16.84
  • 52 Week Range 13.09 - 21.21
  • Volume 591,400
  • Avg. Volume 1,264,622
  • Market Cap (intraday) 2.528B
  • Beta (5Y Monthly) 1.61
  • PE Ratio (TTM) 47.77
  • EPS (TTM) 0.35
  • Earnings Date --
  • Forward Dividend & Yield 0.30 (1.79%)
  • Ex-Dividend Date Sep 25, 2024
  • 1y Target Est --

ChongQing Zhengchuan Pharmaceutical Packaging Co.,Ltd engages in the research and development, manufacturing, and selling of pharmaceutical glass packaging materials in China and internationally. It offers neutral borosilicate glass ampoule and tube injection bottles, low borosilicate tubular vial and ampoule bottles, oral liquid vials, and screw neck vials. The company also provides aluminum caps, aluminum-plastic composite caps, and other medicinal caps. Its products are used in biological preparations, traditional Chinese medicine preparations, and chemical medicines. The company was founded in 1988 and is headquartered in Chongqing, China.

www.cqzcjt.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 603976.SS

View More

Performance Overview: 603976.SS

Trailing total returns as of 4/18/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

603976.SS
3.21%
SSE Composite Index (000001.SS)
2.24%

1-Year Return

603976.SS
23.36%
SSE Composite Index (000001.SS)
6.59%

3-Year Return

603976.SS
32.53%
SSE Composite Index (000001.SS)
2.54%

5-Year Return

603976.SS
10.77%
SSE Composite Index (000001.SS)
15.44%

Compare To: 603976.SS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 603976.SS

View More

Valuation Measures

Annual
As of 4/18/2025
  • Market Cap

    2.53B

  • Enterprise Value

    2.71B

  • Trailing P/E

    47.77

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.18

  • Price/Book (mrq)

    2.07

  • Enterprise Value/Revenue

    3.38

  • Enterprise Value/EBITDA

    13.85

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    6.65%

  • Return on Assets (ttm)

    2.18%

  • Return on Equity (ttm)

    4.37%

  • Revenue (ttm)

    801.12M

  • Net Income Avi to Common (ttm)

    53.25M

  • Diluted EPS (ttm)

    0.35

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    249.48M

  • Total Debt/Equity (mrq)

    35.32%

  • Levered Free Cash Flow (ttm)

    -17.57M

Research Analysis: 603976.SS

View More

Company Insights: 603976.SS

Research Reports: 603976.SS

View More

People Also Watch